Compare Cigna Corp (CI) vs Nano Dimension Ltd - ADR (NNDM) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cigna Corp vs Nano Dimension Ltd - ADR — how do they compare? Cigna Corp trades at $272.72 (market cap $73.56B), while Nano Dimension Ltd - ADR trades at $1.65 (market cap $343.13M). The key difference: Cigna Corp is far larger — about 214.4× Nano Dimension Ltd - ADR's market cap, and Cigna Corp pays a 2.24% dividend while Nano Dimension Ltd - ADR pays none. Which is the better fit depends on your goals.
| CI | NNDM | |
|---|---|---|
Market Cap | $73.56B | $343.13M |
Sector | Health | Technology |
52-Week High | $311.00 | $2.14 |
52-Week Low | $244.41 | $1.21 |
Enterprise Value | $98.27B | -$61.72M |
Dividend Yield | 2.24% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cigna (CI) trades at $282.49, up 2.63% with strong earnings beats in recent quarters. The stock shows bearish technical signals but benefits from low valuation ratios like a P/E of 11.68 and P/S of 0.27. Recent Q2 2026 results exceeded expectations, with EPS of $7.78 beating estimates, and the company raised its full-year guidance to at least $30.45 adjusted EPS, reflecting robust growth in health services and insurance segments.
The outlook is positive due to consistent earnings outperformance and raised guidance, though technical weakness and competitive pressures pose risks. Analyst consensus is strongly bullish with a $338.90 price target, indicating ~20% upside potential from current levels, supported by dividend payments and institutional accumulation.
NNDM trades at $1.63, up 3.82% today, with a bullish technical signal. The company reported Q2 2026 revenue of $121 million and an EPS beat, but net losses persist with a -135.18% margin. Cash burn remains a concern, though strategic asset sales aim to reduce it. Recent news highlights board changes and a planned business combination with Infinite Epigenetics.
The outlook is mixed; cost-saving initiatives and strategic shifts offer potential, but sustained losses and high cash burn pose significant risks. Investor sentiment is cautious amid management turnover and activist shareholder pressure. The stock presents speculative appeal for turnaround bets, but requires careful risk assessment.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cigna Corp
Cigna primarily provides pharmacy benefit management and health insurance services. Its PBM services were greatly expanded by its 2018 merger with Express Scripts and are mostly sold to health insurance plans and employers. Its largest PBM contract is the Department of Defense. In health insurance and other benefits, Cigna mostly serves employers through self-funding arrangements, but it also operates in government programs, such as Medicare Advantage. The company operates mostly in the U.S. with 15 million medical members covered as of the end of 2020, but its services extend internationally, covering another 2 million people.
Read more on CI →About Nano Dimension Ltd - ADR
Nano Dimension Ltd is engaged in research and development of a three-dimensional printer that prints electronic circuit boards, also known as printed circuit boards, and ink materials and products based on nanotechnology. Its products consist of two main product lines - Dragonfly 2020 3D printer and proprietary ink products. The company's Dragonfly 2020 3D printer currently in development uses proprietary ink and integrated software to quickly create fully functioning PCB prototypes. Geographically, it generates maximum revenue from the USA followed by the Asia Pacific and Europe and Israel. It serves the Commercial, Research and Printing services industries.
Read more on NNDM →
